Lexicon and Cetek Enter Natural Products Drug Screening and Technology Agreement
News Apr 28, 2006
Lexicon Genetics Incorporated and Cetek Corporation have announced an agreement under which Cetek will provide Lexicon with a library derived from natural products for use by Lexicon in drug discovery.
Cetek will also utilize its natural products chemistry technologies and chemical biology and scale-up capabilities to isolate and identify compounds with activity against targets screened by Lexicon.
Under the agreement, Lexicon will screen Cetek's premier natural products library, containing 50,000 samples, against a specified number of targets selected by Lexicon from among those discovered and analyzed in its Genome5000™ program.
In this program, Lexicon is using its gene knockout technology to discover the physiological functions of 5,000 potential drug targets.
Compounds contained in Cetek's library that show activity against selected targets may be licensed by Lexicon for drug discovery and development.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019